LIMN NASDAQ
Liminatus Pharma, Inc. Class A Common Stock
1W: -7.1%
1M: +1.6%
3M: -45.3%
YTD: -87.8%
1Y: -95.5%
$3.90
+0.15 (+4.00%)
Weekly Expected Move ±10.0%
$3
$4
$4
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-13M
Net Income
-11154.4% YoY
$-4M
Free Cash Flow
+55.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE294.4%
ROA-471.5%
ROIC252.1%
Valuation
P/E-0.2
P/B6.2
EV/EBITDA-0.1
Leverage
Debt/Equity4.80
Current Ratio1.12
Interest Cov.-164.6x
Quality Scores
Piotroski F4/9
Altman Z-28.46
Beneish M0.00